CVE-2023-23872

Name: CVE-2023-23872
Creator: NVD / NIST
Published: 2024-05-17T07:15:48.92+00:00
License: https://creativecommons.org/publicdomain/zero/1.0/

MEDIUMCVSS 4.9/10EPSS 0.86%

Last modified Jun 17, 2026

CVE-2023-23872 is a medium-severity vulnerability rated 4.9/10 on the CVSS scale. Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') vulnerability in German Mesky GMAce allows Path Traversal.This issue affects GMAce: from n/a through 1.5.2.. EPSS estimates a 0.86% chance of exploitation in the next 30 days.

Description

Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') vulnerability in German Mesky GMAce allows Path Traversal.This issue affects GMAce: from n/a through 1.5.2.

Metrics

CVSS 3.1

4.9/10

CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:U/C:H/I:N/A:N

EPSS Probability

0.86%

53.8th percentile

Probability of exploitation in the next 30 days. Learn more

Weakness Enumeration

CWE-22

References

Timeline

Published: May 17, 2024
Last Modified: Jun 17, 2026
Status: Deferred

Frequently Asked Questions

What is CVE-2023-23872?

Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') vulnerability in German Mesky GMAce allows Path Traversal.This issue affects GMAce: from n/a through 1.5.2.

How severe is CVE-2023-23872?

CVE-2023-23872 has a CVSS score of 4.9/10 (MEDIUM severity). The EPSS model estimates a 0.86% probability of exploitation in the next 30 days.

How do I fix CVE-2023-23872?

Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.

Are you affected by CVE-2023-23872?

Run a free Strix scan to check your systems for this vulnerability.

Scan your code now

Source: NVD / NIST